Multifunctional Probe Based on “Chemical Antibody–Aptamer” for Noninvasive Detection of PD-L1 Expression in Cancer-Reference-Cited by-同舟云学术

Multifunctional Probe Based on “Chemical Antibody–Aptamer” for Noninvasive Detection of PD-L1 Expression in Cancer

Published:2023-12-14 Issue:1 Volume:21 Page:255-266
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Kong Sudong¹²,Liu Qingzhu²,Chen Yinfei²,Liang Beibei²,Zhou Yuxuan²,Lin Jianguo²^ORCID,Xie Minhao¹²,Qiu Ling¹²

Affiliation:

1. School of Chemical and Material Engineering, Jiangnan University, Wuxi 214122, PR China

2. NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, PR China

Funder

Jiangsu Commission of Health

Science Technology and Development Project of Wuxi

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.3c00818

Reference56 articles.

1. Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts

2. Molecular targeting therapies for neuroblastoma: Progress and challenges

3. The Intriguing History of Cancer Immunotherapy

4. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications

5. Camptothesome Potentiates PD-L1 Immune Checkpoint Blockade for Improved Metastatic Triple-Negative Breast Cancer Immunochemotherapy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical Evaluation of a PSMA Aptamer-Based Bifunctional PET and Fluorescent Probe;Bioconjugate Chemistry;2024-08-26